Navigation Links
BIO-key® Announces Third Quarter 2010 Earnings Release and Conference Call Schedule
Date:11/4/2010

WALL, N.J., Nov. 4, 2010 /PRNewswire-FirstCall/ -- BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in finger-based biometric identification solutions, today announced plans to release third quarter 2010 financial results on Wednesday, November 10, 2010.  In conjunction with the release, BIO-key has scheduled a conference call, which will be broadcast live over the Internet on Thursday, November 11, 2010 at 10:00 a.m. Eastern Time.

(Logo: http://photos.prnewswire.com/prnh/20050509/BIOKEYLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO)What:

BIO-key International, Inc. Third Quarter 2010 Conference CallWhen:

Thursday, November 11, 2010 - 10:00 a.m. Eastern TimeWhere:

Live via phone by dialing 800-860-2442 and asking for the BIO-key call at least 10 minutes prior to the start time.  Or live over the Internet by logging on to the web address below.Where:

http://www.bio-key.comA streaming audio replay of the webcast will be available shortly after the call on www.bio-key.com for a period of thirty days.

About BIO-keyBIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft.
BIO-key's technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)

BIO-key Safe Harbor StatementCertain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act").  The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements.  Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act.  These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements.  These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, and our ability to attract and retain key personnel.  For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2009 and its other filings with the Securities and Exchange Commission.  Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made.  The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.


'/>"/>

SOURCE BIO-key International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. BIO-key® Announces Second Quarter 2010 Earnings Release and Conference Call Schedule
2. BIO-key® Awarded Additional Large-Scale Fingerprint Biometric Contract
3. BIO-key® International to Exhibit at Allscripts 2010 Client Experience Conference
4. BIO-key® Reports Strong 2010 Second Quarter and Six Month Financial Results
5. BIO-key® to Unveil Enterprise Ready Biometric Identity Platform for Smartphones at the Burton Group Catalyst Conference
6. General Manifolds LLC Announces Issuance of US Patent in Computational Neuroscience
7. AACR announces new journal, Cancer Discovery
8. CIC Announces Upcoming Webinar: Insurance Consumer Expectations; Customer Experience & Self-Service Will Hit New Highs in 2011! The Role eSignatures Will Play in Meeting that Demand
9. ClinOps Announces Appointment of New President and CEO
10. Aware, Inc. Announces Q310 Earnings Conference Call
11. NYSCF announces 2010 NYSCF Investigators
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... 2016  IMPOWER physicians supporting Medicaid patients in ... clinical standard in telehealth thanks to a new partnership ... platform, IMPOWER patients can routinely track key health measurements, ... index, and, when they opt in, share them with ... a local retail location at no cost. By leveraging ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... Ontario (NSO), which operates the highest sample volume laboratory ... and Tute Genomics and UNIConnect, leaders in clinical sequencing ... announced the launch of a project to establish the ... panel. NSO has been contracted by ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... , June 23, 2016 A person commits ... the crime scene to track the criminal down. ... U.S. Food and Drug Administration (FDA) uses DNA evidence to ... Sound far-fetched? It,s not. The FDA has ... to support investigations of foodborne illnesses. Put as simply as ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge ... envision new ways to harness living systems and biotechnology, ... Art (MoMA) in New York City ... 130 participating students, showcased projects at MoMA,s Celeste Bartos ... Paola Antonelli , MoMA,s senior curator of architecture and ...
Breaking Biology Technology: